Sera from epileptic patients were assayed for phenobarbital and diphenylhydantoin by four different analytical procedures. Quantitative results obtained by radioimmunoassay (I) and enzyme immunoassay (II) were compared to each other and to the results obtained on aliquots of the same sample by gas-liquid chromatography (Ill) and ultraviolet spectrophotometry (IV). (2) (3) (4) (5) (6) with results from spectrophotometric (7-10) and gas-liquid chromatographic (GLC) (11) (12) (13) (14) procedures.5
Materials and Methods

Samples
We assayed sera from 90 epileptic patients referred by physicians for antiepileptic drug screen and from 50 patients admitted to a hospital emergency room for suspected drug overdose. Samples were assayed by the two immunoassay methods and by either spectrophotometry or chromatography. 
Methods
Phenobarbital
EMIT
Immunoassays vs. spectrophotometry (Table 1 , lines j and i). Estimated from the linear regression parameters, the proportional error was about 30%, the constant error was 1.8 mg/liter, and the random error range was 1.6 to 1.9 mg/liter for both immunoassays. The correlation coefficients were 0.862 and 0.898, respectively. In our hands, concentration of 10 mg/liter as determined by the method of Wallace (9) as modified by Dill et al. (10) would correspond to an average value of 11.4 ± 1.9 mg/liter (RIA) or 11.3 ± 1.6 mg/liter (EMIT).
Interferences
A scattergram of the immunoassay results for diphenylhydantoin plotted against the results obtained by gas-liquid chromatography is shown in Figure 1 . 
